Andreas Dalsgaard Jensen1, Henning Bundgaard2, Jawad Haider Butt2, Niels Eske Bruun3, Marianne Voldstedlund4, Christian Torp-Pedersen5, Gunnar Gislason6, Kasper Iversen7, Sandra Chamat8, Anders Dahl6, Lars Køber2, Lauge Østergaard2, Emil Loldrup Fosbøl2. 1. Department of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark. Electronic address: andreas@maehle.dk. 2. Department of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark. 3. Department of Cardiology, Zealand University Hospital, Roskilde, Denmark. 4. Infection Preparedness, Statens Serum Institute, Copenhagen, Denmark. 5. Department of Clinical Epidemiology and Department of Cardiology, University of Aalborg, Aalborg, Denmark. 6. Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Copenhagen, Denmark. 7. Department of Emergency Medicine, Copenhagen University Hospital Herlev and Gentofte, Copenhagen, Denmark. 8. Department of Cardiology, Zealand University Hospital, Roskilde, Denmark; Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Copenhagen, Denmark.
Abstract
BACKGROUND: Infective endocarditis (IE) remains a life-threatening disease, yet substantial variation in reported incidences of the disease exist. We aimed to conduct a contemporary, nationwide study of the temporal changes in incidence of IE. METHODS: We included all Danish cases of first-time IE (1997-2017) using nationwide registries. Patients were grouped into three seven-year intervals (1997-2003, 2004-2010, 2011-2017). Crude annual incidence rates (IR) per 100,000 person-years (PY) were examined overall and per subgroups: age, sex, patients without prior prosthetic heart valve or a cardiac implantable electronic device (CIED). Incidence rate ratios (IRR) were calculated adjusting for age-group, sex and diabetes. RESULTS: We identified 8675 patients with IE. Over time, patients were older at diagnosis with a median age of 66.2 years (interquartile range, IQR: 51.5-76.5) and 72.2 years (IQR 62.2-79.9) in 1997-2003 and 2011-2017, respectively. The overall IR increased from 5.0/100,000 PY (95% CI: 4.4-5.6) to 10.5/100,000 PY (95% CI: 9.6-11.3) from 1997 to 2017. IR for patients without prior prosthetic heart valve or a CIED increased from 4.9/100,000 PY (95% CI: 4.3-5.5) to 6.4/100,000 PY (95% CI: 5.8-7.1) (P ≤ 0.0001 for interaction). The IR in males increased from 5.6/100,000 PY (95% CI: 4.7-6.5) to 14.2/100,000 PY (95% CI: 12.9-15.6). The IR in females increased from 4.3/100,000 PY (95% CI: 3.6-5.2) to 6.7/100,000 PY (95% CI: 5.8-7.7). IRR (adjusted for age-groups, sex and diabetes) increased over time (IRR = 1.60 (1.39-1.85) in 2017 vs 1997). CONCLUSION: The incidence of IE more than doubled during the study period. The increase was mainly seen among men and elderly patients only partly explained by the increase in patients with prior heart valve prosthesis or a CIED.
BACKGROUND:Infective endocarditis (IE) remains a life-threatening disease, yet substantial variation in reported incidences of the disease exist. We aimed to conduct a contemporary, nationwide study of the temporal changes in incidence of IE. METHODS: We included all Danish cases of first-time IE (1997-2017) using nationwide registries. Patients were grouped into three seven-year intervals (1997-2003, 2004-2010, 2011-2017). Crude annual incidence rates (IR) per 100,000 person-years (PY) were examined overall and per subgroups: age, sex, patients without prior prosthetic heart valve or a cardiac implantable electronic device (CIED). Incidence rate ratios (IRR) were calculated adjusting for age-group, sex and diabetes. RESULTS: We identified 8675 patients with IE. Over time, patients were older at diagnosis with a median age of 66.2 years (interquartile range, IQR: 51.5-76.5) and 72.2 years (IQR 62.2-79.9) in 1997-2003 and 2011-2017, respectively. The overall IR increased from 5.0/100,000 PY (95% CI: 4.4-5.6) to 10.5/100,000 PY (95% CI: 9.6-11.3) from 1997 to 2017. IR for patients without prior prosthetic heart valve or a CIED increased from 4.9/100,000 PY (95% CI: 4.3-5.5) to 6.4/100,000 PY (95% CI: 5.8-7.1) (P ≤ 0.0001 for interaction). The IR in males increased from 5.6/100,000 PY (95% CI: 4.7-6.5) to 14.2/100,000 PY (95% CI: 12.9-15.6). The IR in females increased from 4.3/100,000 PY (95% CI: 3.6-5.2) to 6.7/100,000 PY (95% CI: 5.8-7.7). IRR (adjusted for age-groups, sex and diabetes) increased over time (IRR = 1.60 (1.39-1.85) in 2017 vs 1997). CONCLUSION: The incidence of IE more than doubled during the study period. The increase was mainly seen among men and elderly patients only partly explained by the increase in patients with prior heart valve prosthesis or a CIED.
Authors: Christian Johann Lerche; Franziska Schwartz; Mia Marie Pries-Heje; Emil Loldrup Fosbøl; Kasper Iversen; Peter Østrup Jensen; Niels Høiby; Ole Hyldegaard; Henning Bundgaard; Claus Moser Journal: Front Cell Infect Microbiol Date: 2022-02-03 Impact factor: 5.293
Authors: Khawaja M Talha; Larry M Baddour; Martin H Thornhill; Verda Arshad; Wajeeha Tariq; Imad M Tleyjeh; Christopher G Scott; Meredith C Hyun; Kent R Bailey; Nandan S Anavekar; Raj Palraj; M Rizwan Sohail; Daniel C DeSimone; Mark J Dayer Journal: Open Heart Date: 2021-10
Authors: Andreas Dalsgaard Jensen; Lauge Østergaard; Jeppe K Petersen; Peter Graversen; Jawad H Butt; Henning Bundgaard; Claus Moser; Morten H Smerup; Ivy S Modrau; Kasper Iversen; Niels E Bruun; Christian Torp-Pedersen; Gunnar Gislason; Andrew Wang; Sigurdur Ragnarsson; Jonas A Povlsen; Lars Køber; Emil L Fosbøl Journal: BMC Cardiovasc Disord Date: 2022-07-29 Impact factor: 2.174
Authors: Ana Lopez-de-Andres; Rodrigo Jimenez-Garcia; Valentin Hernández-Barrera; Javier de-Miguel-Díez; Jose M de-Miguel-Yanes; David Martinez-Hernandez; David Carabantes-Alarcon; Jose J Zamorano-Leon; Concepción Noriega Journal: Cardiovasc Diabetol Date: 2022-09-30 Impact factor: 8.949
Authors: Christian Johann Lerche; Franziska Schwartz; Marie Theut; Emil Loldrup Fosbøl; Kasper Iversen; Henning Bundgaard; Niels Høiby; Claus Moser Journal: Front Cell Dev Biol Date: 2021-06-18